Biotechgate has grown a lot over the course of the year. In total, the Biotechgate database has over 1.1 million active entries and several millions of records including historical data. Managing this volume of information is challenging, both from a technical point of view as well as being able to find the information you want … Continue reading Enjoy an Enhanced User Experience With Our New Website Release
Category: Publications & News
In this chapter we publish articles about Biotechgate as well as Biotech related topics. Also most of the articles published in newsletters are available here.
How to Find Diagnostic Assets in Biotechgate
Assets listed in Biotechgate are grouped into four sections: therapeutics, molecular diagnostics, medical devices and technologies. The divide is rather logical, but for some users, especially those familiar with the classification of products for regulatory purposes, it may not be clear how we distinguish molecular diagnostics from diagnostic medical devices. In this article, we discuss … Continue reading How to Find Diagnostic Assets in Biotechgate
Dutch Life Sciences Trend Analysis 2021 – Biotech Companies Show To Be Resilient And See Venture Financing Grow In 2020
Wednesday, 3 March 2021 Biotechgate, the leading global biotech database, presents their annual Trend Analysis Report 2021 of the Dutch life sciences sector. The report shows the resilience of the Dutch biotech sector. Although the coronavirus had a negative impact on the amount of clinical trials, biotech companies attracted double the amount of venture … Continue reading Dutch Life Sciences Trend Analysis 2021 – Biotech Companies Show To Be Resilient And See Venture Financing Grow In 2020
Korean Life Science Market Trend Analysis 2021
We are presenting the Korean Life Science Market Trend Analysis 2021 prepared in cooperation with our partner Seoul BioHub operated by KHIDI (Korea Health Industry Development Institute).
Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate
Media release Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate Zurich / Vilnius, Jan 2021 Venture Valuation/Biotechgate announce a cooperation with Enterprise Lithuania, trade promotion governmental agency. As per the agreement of the two parties, the Lithuanian Biotech Database has been set-up, a regional portal integrated with Biotechgate Business Development Database. Access to the portal … Continue reading Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate
Winning start-ups as customers – timing is crucial
Working with start-ups can be both highly promising and risky. On the one hand, there is no greater potential for the future as with an emerging company. On the other hand, new entrepreneurs often lack the funds to be able to make a long-term commitment with partners and suppliers. That is why the right timing … Continue reading Winning start-ups as customers – timing is crucial
Trends and facts on licensing deals
Biotechgate Digital Partnering, virtual, November 2020, 23 pages Presentation
Life science asset database
We regularly hear about new licensing agreements between pharmaceutical and biotech companies. These usually involve assets – such as therapeutics, diagnostics, medical devices or technologies – which are to be developed or marketed together. A big challenge however is to find the right partner for the right asset. The Biotechgate database features almost 90,000 life … Continue reading Life science asset database
Launch of the Life Science Directory for Medicen Paris
Media Release Launch of the Life Science Directory for Medicen Paris Zurich / Paris, Oct 2020 – Venture Valuation owned Biotechgate announces the partnership with Medicen Paris Region to create a directory of Life Sciences companies. The online directory makes it easier to find partners in one of the key clusters in Europe. Venture Valuation/Biotechgate … Continue reading Launch of the Life Science Directory for Medicen Paris
Canadian Life Science Market Trend Analysis 2020
Together with our partners – Montreal Invivo, BioAlberta and BIOTECanada – we are happy to present an extended annual report on the Canadian life science market. Besides the usual statistics about companies, products and investments, the new format of the report includes data on clinical trials acquired from the new section of Biotechgate database.